Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Change in Inventory (2019 - 2025)

AVITA Medical's Change in Inventory history spans 7 years, with the latest figure at -$198000.0 for Q4 2025.

  • For Q4 2025, Change in Inventory fell 117.69% year-over-year to -$198000.0; the TTM value through Dec 2025 reached $468000.0, down 78.33%, while the annual FY2025 figure was $468000.0, 78.33% down from the prior year.
  • Change in Inventory reached -$198000.0 in Q4 2025 per RCEL's latest filing, down from -$144000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $1.7 million in Q1 2024 to a low of -$629000.0 in Q2 2025.
  • Average Change in Inventory over 5 years is $342000.0, with a median of $204000.0 recorded in 2022.
  • Peak YoY movement for Change in Inventory: soared 425.0% in 2023, then crashed 225.3% in 2024.
  • A 5-year view of Change in Inventory shows it stood at $293000.0 in 2021, then fell by 13.99% to $252000.0 in 2022, then surged by 411.11% to $1.3 million in 2023, then fell by 13.12% to $1.1 million in 2024, then tumbled by 117.69% to -$198000.0 in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Change in Inventory are -$198000.0 (Q4 2025), -$144000.0 (Q3 2025), and -$629000.0 (Q2 2025).